Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
Actual shortage: | 249 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
36 (14%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT REPAGLINIDE | 1MG | TABLET | Actual shortage | 2021-11-18 | 2021-11-18 | 149596 |
ACT REPAGLINIDE | 0.5MG | TABLET | Actual shortage | 2021-11-18 | 2021-11-18 | 149591 |
TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2021-10-21 | 2021-11-18 | 147696 |
TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2021-09-23 | 2021-11-18 | 146112 |
ACT EXEMESTANE | 25MG | TABLET | Resolved | 2021-09-23 | 2021-11-18 | 146089 |
TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2021-08-27 | 2021-11-18 | 144707 |
TEVA-TRIACOMB | 1MG 100000UNIT 2.5MG 0.25MG | CREAM | Resolved | 2021-04-15 | 2021-11-18 | 137538 |
TEVA-TRIACOMB | 1MG 100000UNIT 2.5MG 0.25MG | CREAM | Resolved | 2021-03-04 | 2021-11-18 | 135132 |
TEVA-MELOXICAM | 7.5MG | TABLET | Resolved | 2021-11-04 | 2021-11-11 | 148841 |
TEVA-OMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-10-21 | 2021-11-11 | 147711 |
TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-10-07 | 2021-11-11 | 146853 |
TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-10-07 | 2021-11-11 | 146847 |
TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2021-09-30 | 2021-11-11 | 146456 |
TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-09-30 | 2021-11-11 | 146449 |
TEVA-BISOPROLOL | 10MG | TABLET | Resolved | 2021-09-23 | 2021-11-11 | 146101 |
TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-09-16 | 2021-11-11 | 145791 |
TEVA-MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-08-27 | 2021-11-11 | 144755 |
TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2021-07-29 | 2021-11-05 | 143262 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-09-30 | 2021-11-05 | 146469 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-10-07 | 2021-11-05 | 146856 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64923 |
NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |
TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64909 |
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
TEVA-ENALAPRIL | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64869 |
TEVA-ENALAPRIL | 16MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64866 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64861 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64609 |